Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose–response meta-analysis of prospective studies

References

• Beatty, A.L., et al., 2013. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA internal medicine, 173(9), 763–769.
   PubMed Web of Science ®Google Scholar
• Benjamin, E.J., et al., 2018. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation, 137(12), e67–e492.
   PubMed Web of Science ®Google Scholar
• Biener, M., et al., 2016. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease. European heart Journal: acute cardiovascular care, 5 (6), 409–418.
   PubMed Web of Science ®Google Scholar
• Carda, R., et al., 2015. The prognostic value of high-sensitive troponin I in stable coronary artery disease depends on age and other clinical variables. Cardiology, 132(1), 1–8.
   PubMed Web of Science ®Google Scholar
• de Lemos, J.A., 2013. Increasingly sensitive assays for cardiac troponins: a review. JAMA, 309(21), 2262–2269.
   PubMed Web of Science ®Google Scholar
• DerSimonian, R. and Laird, N., 1986. Meta-analysis in clinical trials. Controlled clinical trials, 7(3), 177–188.
   PubMedGoogle Scholar
• Dieplinger, B., et al., 2014. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study. Clinical chemistry, 60(3), 530–540.
   PubMed Web of Science ®Google Scholar
• Egger, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ (clinical research ed.), 315(7109), 629–634.
   PubMed Web of Science ®Google Scholar
• Eggers, K.M., et al., 2007. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation, 116(17), 1907–1914.
   PubMed Web of Science ®Google Scholar
• Everett, B.M., et al., 2015. Troponin and cardiac events in stable ischemic heart disease and diabetes. The new England journal of medicine, 373(7), 610–620.
   PubMed Web of Science ®Google Scholar
• Flores, E., et al., 2018. Do the SGLT-2 inhibitors offer more than hypoglycemic activity? Cardiovascular drugs and therapy, 32(2), 213–222.
   PubMed Web of Science ®Google Scholar
• Giannitsis, E., et al., 2013. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clinical chemistry and laboratory medicine, 51(10), 2019–2028.
   PubMed Web of Science ®Google Scholar
• Gitsioudis, G., et al., 2015. Combined assessment of high-sensitivity troponin T and noninvasive coronary plaque composition for the prediction of cardiac outcomes. Radiology, 276(1), 73–81.
   PubMed Web of Science ®Google Scholar
• Greenland, S. and Longnecker, M.P., 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. American journal of epidemiology, 135(11), 1301–1309.
   PubMed Web of Science ®Google Scholar
• Harada, Y., et al., 2016. Prognostic value of cardiac troponin T and sex in patients undergoing elective percutaneous coronary intervention. Journal of the American Heart Association, 5(12), pii:e004464.
   Web of Science ®Google Scholar
• Heresi, G.A., et al., 2012. Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension. The European respiratory journal, 39(4), 939–944.
   PubMed Web of Science ®Google Scholar
• Higgins, J.P., and Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21(11), 1539–1558.
   PubMed Web of Science ®Google Scholar
• Hsieh, B.P., et al., 2009. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study. American heart journal, 158(4), 673–679.
   PubMed Web of Science ®Google Scholar
• Januzzi, J.L., Jr., et al., 2017. Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. Journal of the American college of cardiology, 70(6), 704–712.
   PubMed Web of Science ®Google Scholar
• Jeremias, A., et al., 2008. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation, 118(6), 632–638.
   PubMed Web of Science ®Google Scholar
• Khan, N.A., et al., 2005. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation, 112(20), 3088–3096.
   PubMed Web of Science ®Google Scholar
• Koenig, W., et al., 2012. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clinical chemistry, 58(8), 1215–1224.
   PubMed Web of Science ®Google Scholar
• Ky, B., et al., 2014. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. Journal of the American college of cardiology, 63(8), 809–816.
   PubMed Web of Science ®Google Scholar
• Lepojarvi, E.S., et al., 2016. Usefulness of highly sensitive troponin as a predictor of short-term outcome in patients with diabetes mellitus and stable coronary artery disease (from the ARTEMIS study). American Journal of cardiology, 117(4), 515–521.
   PubMed Web of Science ®Google Scholar
• Lupi, A., et al., 2016. Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions. EuroIntervention, 11(12), 1380–1388.
   PubMed Web of Science ®Google Scholar
• Lyngbaek, S., et al., 2014. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. European journal of preventive cardiology, 21(10), 1275–1284.
   PubMed Web of Science ®Google Scholar
• Ma, L., and Zhao, S., 2017. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. International journal of cardiology, 238, 151–158.
   PubMed Web of Science ®Google Scholar
• Miller, W.L., et al., 2006. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. European heart journal, 27(9), 1061–1069.
   PubMed Web of Science ®Google Scholar
• Mohammad, M.A., et al., 2018. Predictive value of high-sensitivity troponin T for systolic dysfunction and infarct size (six months) after ST-elevation myocardial infarction. American Journal of cardiology, 122(5), 735–743.
   PubMed Web of Science ®Google Scholar
• Montalescot, G., et al., 2013. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European heart Journal, 34, 2949–3003.
   PubMed Web of Science ®Google Scholar
• Nagarajan, V., Hernandez, A.V., and Tang, W.H., 2012. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart (British cardiac society), 98(24), 1778–1786.
   PubMed Web of Science ®Google Scholar
• Ndrepepa, G., et al., 2011. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. American heart journal, 161(1), 68–75.
   PubMed Web of Science ®Google Scholar
• Ndrepepa, G., et al., 2011. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina. European journal of clinical investigation, 41(10), 1054–1062.
   PubMed Web of Science ®Google Scholar
• Oemrawsingh, R.M., et al., 2016. High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study. Atherosclerosis, 247, 135–141.
   PubMed Web of Science ®Google Scholar
• Omland, T., et al., 2009. A sensitive cardiac troponin T assay in stable coronary artery disease. The new England journal of medicine, 361(26), 2538–2547.
   PubMed Web of Science ®Google Scholar
• Omland, T., et al., 2013. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. Journal of the American college of cardiology, 61(12), 1240–1249.
   PubMed Web of Science ®Google Scholar
• Roffi, M., et al., 2016. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European heart journal, 37, 267–315.
   PubMed Web of Science ®Google Scholar
• Santos-Gallego, C.G., et al., 2016. Sphingosine-1-phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia/reperfusion. Circulation, 133(10), 954–966.
   PubMed Web of Science ®Google Scholar
• Stroup, D.F., et al., 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283(15), 2008–2012.
   PubMed Web of Science ®Google Scholar
• Thygesen, K., et al., 2012. Third universal definition of myocardial infarction. Circulation, 126(16), 2020–2035.
   PubMed Web of Science ®Google Scholar
• Wang, T.J., et al., 2012. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation, 126(13), 1596–1604.
   PubMed Web of Science ®Google Scholar
• Weil, B.R., et al., 2018. Troponin release and reversible left ventricular dysfunction after transient pressure overload. Journal of the American college of cardiology, 71(25), 2906–2916.
   PubMed Web of Science ®Google Scholar
• White, H.D., et al., 2014. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID study (long-term intervention with pravastatin in ischaemic disease). Journal of the American college of cardiology, 63(4), 345–354.
   PubMed Web of Science ®Google Scholar
• Willeit, P., et al., 2017. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. Journal of the American college of cardiology, 70(5), 558–568.
   PubMed Web of Science ®Google Scholar
• Zanchin, T., et al., 2016. Preprocedural high-sensitivity cardiac troponin T and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. Circulation: cardiovascular interventions, 9, pii:e003203.
   Web of Science ®Google Scholar